Vipharma SRL
0.8 FTEThe score of Vipharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -8 % Headcount (avg FTE) -27 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vipharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Mar 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 05 Jun 2023
Vipharma's financial analysis
- Solvency8.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vipharma
Vipharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0774.494.916
- VAT number
- BE0774494916
- Peppol
- Registered · 0208:0774494916 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Sep 2021
- Registered office
- 7332 Saint-Ghislain
- Size
- Micro · 0.8 FTE
- Latest accounts
- 2025 · filed on 31 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Vipharma (SRL) has been based in Saint-Ghislain since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 10,208 € and equity of 41,535 €; its revenue is not published. With 0.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 8.9%, below the median of its sector (41.5%).
Companies similar to Vipharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Carlier Retail sale of pharmaceutical products Beloeil · balance sheet 473,210 €
- MV Pharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 469,186 €
- Apotheek ELS Verfaillie N.V. Retail sale of pharmaceutical products Wemmel · balance sheet 466,926 €
- Vancophar Retail sale of pharmaceutical products Bierbeek · balance sheet 466,628 €
- Bephar Retail sale of pharmaceutical products Frameries · balance sheet 466,425 €
- PharmaConseil Retail sale of pharmaceutical products Verviers · balance sheet 468,687 €
- Frencken Retail sale of pharmaceutical products Antwerp · balance sheet 464,818 €
- Jely Pharma Retail sale of pharmaceutical products Incourt · balance sheet 469,684 €
Frequently asked questions about Vipharma
What is the revenue of Vipharma?
Vipharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vipharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0774494916 for Vipharma, if the company is VAT-registered. Its company number (CBE) is 0774.494.916.
Where is the registered office of Vipharma?
According to the CBE register, the registered office of Vipharma is in 7332 Saint-Ghislain.
What is the equity of Vipharma?
At the close of the 2025 financial year, the equity of Vipharma amounts to 41,535 €, a solvency of 8.9% of total assets.
How many people work at Vipharma?
0.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Vipharma?
The register lists 3 active mandates at Vipharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vipharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →